CASP9 and glioblastoma: In concordance with these data, Western blot analyses showed that cleavage of caspases 9 and 3 was also markedly enhanced following treatment of U87MG (B), T98G (C), U251 (D) and SF188 (E) glioblastoma cells with increasing concentrations of WP1130 (Figure 2B–2E).